Wealth Enhancement Advisory Services LLC Has $14.70 Million Stock Holdings in Humana Inc. $HUM

Wealth Enhancement Advisory Services LLC lifted its stake in shares of Humana Inc. (NYSE:HUM) by 287.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,512 shares of the insurance provider’s stock after acquiring an additional 38,962 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Humana were worth $14,699,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Rosenberg Matthew Hamilton lifted its position in shares of Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 68 shares during the period. Elevation Point Wealth Partners LLC acquired a new stake in shares of Humana during the second quarter worth $32,000. Mather Group LLC. bought a new position in Humana during the third quarter worth $34,000. Private Wealth Management Group LLC raised its stake in Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after buying an additional 48 shares during the last quarter. Finally, Larson Financial Group LLC lifted its holdings in Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after buying an additional 81 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

HUM has been the topic of a number of research analyst reports. Guggenheim cut their price target on shares of Humana from $312.00 to $252.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th. UBS Group reissued a “neutral” rating on shares of Humana in a research note on Wednesday, February 25th. Truist Financial cut their target price on Humana from $285.00 to $200.00 and set a “hold” rating on the stock in a research report on Tuesday, February 17th. Barclays decreased their target price on Humana from $245.00 to $176.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 24th. Finally, Wells Fargo & Company dropped their price target on Humana from $290.00 to $206.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 18th. Seven analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $225.48.

Humana Stock Performance

Shares of HUM opened at $174.05 on Thursday. Humana Inc. has a one year low of $163.11 and a one year high of $315.35. The company has a market cap of $20.90 billion, a PE ratio of 17.72, a P/E/G ratio of 1.84 and a beta of 0.44. The stock has a 50-day moving average of $195.99 and a 200-day moving average of $240.31. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.00 and a quick ratio of 2.00.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, topping analysts’ consensus estimates of ($4.01) by $0.05. Humana had a return on equity of 11.43% and a net margin of 0.92%.The business had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $32.08 billion. During the same period in the prior year, the business earned ($2.16) EPS. The firm’s revenue for the quarter was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, equities research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Friday, March 27th. Humana’s dividend payout ratio is currently 36.05%.

Insider Buying and Selling at Humana

In other Humana news, insider Sanjay K. Shetty purchased 810 shares of the company’s stock in a transaction that occurred on Monday, February 23rd. The shares were acquired at an average price of $185.21 per share, with a total value of $150,020.10. Following the transaction, the insider owned 11,657 shares in the company, valued at $2,158,992.97. The trade was a 7.47% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.20% of the stock is owned by corporate insiders.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.